Apyx Medical Corp. (NASDAQ: APYX) reported Q1 EPS of ($0.10), $0.02 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $9.4 million versus the consensus estimate of $9.35 million.

GUIDANCE:

Apyx Medical Corp. sees FY2025 revenue of $47.6-49 million, versus the consensus of $48.03 million.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.